BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19227908)

  • 1. [Hairy cell leukemia in young patients].
    Al'-Radi LS; Samoĭlova RS; Tikhonova LIu; Diagileva OA; Naumova IN; Kaplanskaia IB; Varlamova EIu
    Ter Arkh; 2008; 80(12):53-8. PubMed ID: 19227908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
    Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The disease with hope: hairy cell leukemia.
    Becker SE
    Clin J Oncol Nurs; 2007 Oct; 11(5):731-5. PubMed ID: 17962181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment for recurrent hairy cell leukemia].
    Al'-Radi LS; Pivnik AV; Zingerman BV; Kravchenko SK
    Ter Arkh; 2012; 84(7):4-9. PubMed ID: 23038964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnosis of hairy cell leukemia can be established by flow cytometric analysis of peripheral blood, even in patients with low levels of circulating malignant cells.
    Cornfield DB; Mitchell Nelson DM; Rimsza LM; Moller-Patti D; Braylan RC
    Am J Hematol; 2001 Aug; 67(4):223-6. PubMed ID: 11443633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cladribine in hairy cell leukemia.
    Belani R; Saven A
    Hematol Oncol Clin North Am; 2006 Oct; 20(5):1109-23. PubMed ID: 16990111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current treatment options in hairy cell leukemia and hairy cell leukemia variant.
    Robak T
    Cancer Treat Rev; 2006 Aug; 32(5):365-76. PubMed ID: 16781083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.
    Else M; Ruchlemer R; Osuji N; Del Giudice I; Matutes E; Woodman A; Wotherspoon A; Swansbury J; Dearden C; Catovsky D
    Cancer; 2005 Dec; 104(11):2442-8. PubMed ID: 16245328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hairy cell leukemia: towards a curative strategy.
    Gidron A; Tallman MS
    Hematol Oncol Clin North Am; 2006 Oct; 20(5):1153-62. PubMed ID: 16990114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of interferon-alpha induction and low-dose maintenance therapy in hairy cell leukemia.
    Benz R; Siciliano RD; Stussi G; Fehr J
    Eur J Haematol; 2009 Mar; 82(3):194-200. PubMed ID: 19077050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hairy cell leukemia: an elusive but treatable disease.
    Wanko SO; de Castro C
    Oncologist; 2006; 11(7):780-9. PubMed ID: 16880237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successful treatment with cladribine for hypoplastic hairy cell leukemia after long-term neutropenia].
    Sakai R; Yamazaki E; Sakamoto H; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2005 Nov; 46(11):1187-90. PubMed ID: 16440801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hairy cell leukemia: current concepts.
    Cannon T; Mobarek D; Wegge J; Tabbara IA
    Cancer Invest; 2008 Oct; 26(8):860-5. PubMed ID: 18798068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of recombinant interferon alpha-2 in 34 patients with hairy cell leukemia. Effect of splenectomy and dosage reduction results of therapy].
    Frey B; Hofmann V; Cavalli F; Fehr J; Kroner T; Nesthus I; Schwarzmeier J
    Schweiz Med Wochenschr; 1988 Oct; 118(41):1468-75. PubMed ID: 3238389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recurrent somatic mutation in hairy cell leukemia].
    Sári E; Nagy Z; Demeter J
    Orv Hetil; 2013 Jan; 154(4):123-7. PubMed ID: 23335721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hairy-cell leukaemia: first-line treatment with cladribine or pentostatin.
    Prescrire Int; 2006 Aug; 15(84):143-4. PubMed ID: 16989031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for severe infection in patients with hairy cell leukemia: a long-term study of 73 patients.
    Damaj G; Kuhnowski F; Marolleau JP; Bauters F; Leleu X; Yakoub-Agha I
    Eur J Haematol; 2009 Sep; 83(3):246-50. PubMed ID: 19302557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hairy cell leukemia: evaluation of the long-term outcome in 121 patients.
    Zinzani PL; Pellegrini C; Stefoni V; Derenzini E; Gandolfi L; Broccoli A; Argnani L; Quirini F; Pileri S; Baccarani M
    Cancer; 2010 Oct; 116(20):4788-92. PubMed ID: 20597132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of alpha-interferon in the treatment of hairy-cell leukemia].
    Pagnucco G; Castelli G; Lazzarino M; Bernasconi C
    Haematologica; 1990; 75 Suppl 4():56-67. PubMed ID: 2074056
    [No Abstract]   [Full Text] [Related]  

  • 20. Hairy cell leukaemia in the Bloemfontein academic hospitals.
    Nel T; Joubert G; van der Ryst E; Bester I
    Cent Afr J Med; 1998 Nov; 44(11):286-9. PubMed ID: 10189750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.